PROXY STATEMENT - SPECIAL

Company

Ernexa Therapeutics Inc.

Filed

September 3, 2004

Period of Report

August 16, 2004

Accession Number

0000748592-04-000036

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →